webex: https://uwhealth.webex.com/uwhealth/j.php?MTID=m3e0079841c164c924e50bf2b3a66aaaf

objectives:

  • Summarize the literature describing the increased risk of nephrotoxicity with combination piperacillin/tazobactam-vancomycin vs cefepime-vancomycin
  • Describe the mechanism of piperacillin/tazobactam-vancomycin nephrotoxicity
  • Identify other mechanisms that may contribute to piperacillin/tazobactam-vancomycin “nephrotoxicity”
Session date: 
04/02/2024 - 1:00pm to 2:00pm CDT
Location: 
In-person and Virtually
Will be determined by room availability
600 Highland Ave
Madison, WI 53705
United States
See map: Google Maps
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 ACPE Contact Hours - Pharmacist Technician
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
Add to calendar: 

Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Ethan Meyer, PharmD